Rosiglitazone Rescues Memory Impairment in Alzheimer's Transgenic Mice: Mechanisms Involving a Reduced Amyloid and Tau Pathology

Clinical studies suggest that agonists at peroxisome proliferator-activated receptor gamma (PPARγ) may exert beneficial effects in patients with mild-to-moderate Alzheimer's disease (AD), but the mechanism for the potential therapeutic interest of this class of drugs has not yet been elucidated...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Escribano, Luis, Simón, Ana-María, Gimeno, Esther, Cuadrado-Tejedor, Mar, López de Maturana, Rakel, García-Osta, Ana, Ricobaraza, Ana, Pérez-Mediavilla, Alberto, Del Río, Joaquín, Frechilla, Diana
Natura: Artigo
Lingua:Inglês
Pubblicazione: Nature Publishing Group 2010
Soggetti:
Original Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3055461/
https://ncbi.nlm.nih.gov/pubmed/20336061
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/npp.2010.32
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi